Specialists have reported new findings from a study documenting cognitive dysfunction, and evaluating the Montreal Cognitive Assessment (MoCA) as a screening tool, in patients with newly diagnosed high-grade (WHO grade III and IV) gliomas.
News
News
Daily digests from key neurology conferences, written by on-site medical journalists.
Published: 22 sep. 2019